Digital Health Acquisition Corp. is a special purpose acquisition company (SPAC) formed in 2019 and listed on the Nasdaq under the symbol DHAC. The firm was established to raise capital through an initial public offering and pursue a business combination with an operating company in the digital health sector. While the SPAC itself does not conduct commercial operations, it provides investors with targeted exposure to the rapidly evolving digital healthcare market.
Digital Health Acquisition focuses on identifying businesses that deliver value through telemedicine, digital therapeutics, health data analytics, medical devices, and remote patient monitoring solutions. The company evaluates potential partners based on market opportunity, regulatory readiness, technological innovation, and scalability. By concentrating on these core areas, DHAC aims to facilitate the merger of capital and expertise to support growth-stage digital health enterprises.
Headquartered in Greenwich, Connecticut, DHAC seeks opportunities both in the U.S. and internationally, leveraging an advisory network of healthcare strategists, technology specialists, and financial experts. This multidisciplinary team conducts rigorous due diligence, assesses competitive landscapes, and navigates compliance requirements across jurisdictions. Their combined insight enables the SPAC to identify targets with the potential to redefine patient care and streamline healthcare delivery.
The management team comprises seasoned executives with backgrounds in venture capital, biotechnology, health information technology, and corporate governance. Under a defined timeline to complete a qualifying business combination, the company emphasizes transparency, shareholder alignment, and disciplined deal structuring. Upon closing a merger, the resulting public entity is positioned to advance digital health innovation while offering investors a direct stake in the sector’s growth trajectory.
AI Generated. May Contain Errors.
Free DHAC Stock Alerts